查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
分子診斷的全球市場:市場規模，市場佔有率，趨勢分析，機會，預測:各產品，各技術，各終端用戶，各用途，各地區(2018年～2028年)
市場調查報告書
商品編碼
1147293

分子診斷的全球市場:市場規模，市場佔有率，趨勢分析，機會，預測:各產品，各技術，各終端用戶，各用途，各地區(2018年～2028年)

Molecular Diagnostics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018-2028, Segmented By Product ; By Technology ; By End User ; By Application ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 410 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球分子診斷的市場規模，從2021年的165億1,000萬美元預計到2028年達到394億美元，在預測期間(2022年～2028年)以11.3％的年複合成長率成長。分子診斷的技術開拓發展，在新興國家的疾病早期診斷的認識高漲，促進分子診斷市場成長。

本報告提供全球分子診斷市場的相關調查，市場概要，市場分析，企業簡介等全面性資訊。

目錄

第1章 調查架構

第2章 摘要整理

第3章 全球分子診斷市場洞察

  • 產業價值鏈分析
  • DROC分析
    • 促進因素
      • 感染疾病和癌症的盛行率增加
      • 檢驗成本的削減和調查活動增加
      • 對一般社會的認識度提高
    • 阻礙因素
      • 由於缺乏恰當的計費指南的不利償付
      • 其他
    • 機會
      • 新興國家的成長機會
      • 遺傳基因檢驗的需求高漲
      • 其他
    • 課題
      • 嚴格的法律規範
      • 替代技術的簡介
  • 波特的五力分析
    • 供給企業談判力
    • 買方議價能力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭的激烈程度

第4章 全球分子診斷市場概要

  • 市場規模與預測(2018年～2028年):各金額
    • 各金額(10億美元)
  • 市場佔有率與預測
    • 各產品
      • 設備
      • 試劑
      • 其他
    • 各技術
      • 聚合酵素鏈鎖反應(PCR)
      • 雜合反應
      • DNA定序
      • 微陣列
      • 恆溫核酸增幅技術(INAAT)
      • 其他
    • 各終端用戶
      • 診斷檢驗室
      • 醫院和診所
      • 研究機關
      • 其他
    • 各用途
      • 傳染病檢查
      • 腫瘤檢驗
      • 藥物基因體學
      • 遺傳基因檢驗
      • 血液篩檢
      • 神經疾病
      • 循環系統疾病檢驗
      • 微生物檢驗
      • 其他
    • 各地區
      • 北美
      • 歐洲
      • 亞太地區
      • 南美
      • 中東及非洲

第5章 北美的分子診斷市場

    • 市場規模與預測(2018年～2028年):各金額
    • 各金額(10億美元)
  • 市場佔有率與預測
    • 各產品
    • 各技術
    • 各終端用戶
    • 各用途
    • 各國
      • 美國
      • 加拿大

第6章 歐洲的分子診斷藥市場

  • 市場規模與預測(2018年～2028年):各金額
    • 各金額(10億美元)
  • 市場佔有率與預測
    • 各產品
    • 各技術
    • 各終端用戶
    • 各用途
    • 各國
      • 德國
      • 英國
      • 義大利
      • 法國
      • 西班牙
      • 荷蘭
      • 比利時
      • 北歐各國
      • 其他歐洲

第7章 亞太地區的分子診斷市場

  • 市場規模與預測(2018年～2028年):各金額
    • 各金額(10億美元)
  • 市場佔有率與預測
    • 各產品
    • 各技術
    • 各終端用戶
    • 各用途
    • 各國
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳洲和紐西蘭
      • 印尼
      • 馬來西亞
      • 新加坡
      • 菲律賓
      • 越南
      • 其他亞太地區

第8章 南美的分子診斷市場

  • 市場規模與預測(2018年～2028年):各金額
    • 各金額(10億美元)
  • 市場佔有率與預測
    • 各產品
    • 各技術
    • 各終端用戶
    • 各用途
    • 各國
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 哥倫比亞
      • 其他南美國家

第9章 中東及非洲的分子診斷市場

  • 市場規模與預測(2018年～2028年):各金額
    • 各金額(10億美元)
  • 市場佔有率與預測
    • 各產品
    • 各技術
    • 各終端用戶
    • 各用途
    • 各國
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 科威特
      • 伊朗
      • 南非
      • 奈及利亞
      • 肯亞
      • 埃及
      • 摩洛哥
      • 阿爾及利亞
      • 其他中東

第10章 競爭情形

  • 主要企業與其產品的清單
  • 企業的市場佔有率分析(2021年)
  • 競爭基準:各操作參數
  • 主要的策略性展開(合併，收購，夥伴關係等)

第11章 COVID-19對全球分子診斷市場產業的影響

第12章 企業簡介(企業概要，財務矩陣，競爭情形，主要的人員，主要的競爭，聯絡原住所，策略性展望)

  • ABOTT LABORATORIES
  • Agilent Technologies Inc.
  • BECTON DICKINSON AND COMPANY
  • BIOMERIEUX SA
  • HOFFMON LA-ROCHE LTD
  • GRIFOLS S.A.
  • HOLOGIC INC.
  • QIAGEN INC
  • SIEMENS AG
  • 其他

第13章 主要策略性推薦事項

第14章 調查手法

簡介目錄
Product Code: BWC20325

Global Molecular Diagnostics Market Flourishing at Robust 11.3% CAGR during Forecast Period

The global molecular diagnostics market is thriving because of rising technological developments in molecular diagnostics and a growing awareness of early disease diagnosis in emerging nations are driving market expansion.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global molecular diagnostics market at USD 16.51 billion in 2021. During the forecast period between 2022 and 2028, the size of global molecular diagnostics market is projected to grow at a CAGR of 11.3%, to reach a value of USD 39.4 billion by 2028. Global outbreaks of severe infectious diseases caused by pathogenic microorganisms have posed a huge threat to public health around the world, motivating researchers to create speedy and effective pathogen detection technologies. Traditionally, culture-based pathogen detection techniques have been considered gold standards. However, the significant turnaround time associated with these procedures, due to overnight culturing and pathogen isolation, limits their use. The invention and implementation of molecular diagnostic tools have ushered in a revolution in the diagnosis and surveillance of infectious diseases in recent years.

Global Molecular Diagnostics Market - Overview

Cellular-Molecular diagnostics is a broad term that refers to a group of diagnostic tests that examine a person's health on a cellular and molecular level, detecting and measuring specific cellular alterations, genetic sequences in deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), amino acids, and the proteins they express. The recent advancements in diagnostics such as PCR have gained popularity in recent years due to detection of infectious diseases and genetic modifications. This works by identifying the pathogenic DNA/RNA or abnormalities in cell culture. Molecular diagnostics work efficiently in producing highly accurate results. Furthermore, diagnostic companies have adopted advanced technologies like Artificial Intelligence to render products and services that could produce results in minimal duration with precision.

Impact of COVID-19 on Global Molecular Diagnostics Market

Coronavirus disease (COVID-19) is an extremely contagious illness. The COVID-19 virus causes mild to moderate respiratory disease in those who are infected. In December 2019, the COVID-19 strain was discovered in Wuhan, Hubei Province, China. It has since spread to various countries throughout the world, prompting the WHO to declare it a pandemic. COVID-19 molecular diagnostic testing has proven critical in the global response to the epidemic. Government organizations around the world are assisting laboratories in expediting COVID-19 testing methods since testing remains a critical step in preventing the disease's rapid spread. As a result, regulatory agencies used techniques to expedite the licensing of molecular diagnostic products.

Corporations have made strategic investments to adopt COVID-19 quick tests and reduce the impact of COVID-19 on their operating capabilities. Diagnostic testing continues to be the backbone of the COVID-19 response, enabling containment and mitigation activities. The severity of the crisis as well as the growing capacity issues associated with PCR-based testing pushed the development of diagnostic solutions to fulfill the demand for mass testing. COVID-19 testing and tracking procedures were built up by major players in the market. Various profiling methods, such as PCR testing panels and medicines, were approved by the FDA for emergency use in COVID-19 testing and diagnostics. Such advancements could drive global molecular diagnostics market.

Global Molecular Diagnostics Market - Regional Analysis

Developing economies, such as India, China, Brazil, Turkey, and South Africa could drive global molecular diagnostics market, as these countries' high disease prevalence, big patient population, expanding healthcare infrastructure, rising disposable income, and growing medical tourism. In addition to the above-mentioned characteristics, Asia Pacific has developed as a flexible and business-friendly center due to its tax regulatory and data requirements.

Competitive Landscape

The global market for molecular diagnostics is fiercely competitive with a number of prominent players. Mid-sized to small businesses, on the other hand, are expanding their market presence by releasing new devices at lower rates, all thanks to technical improvements and product innovations. Key companies in global molecular diagnostics market include Abbott Laboratories, F Hoffmann-la Roche Ltd, Hologic Corporation, Danaher Corporation, and Agilent Technology.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Molecular Diagnostics Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Molecular Diagnostics Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Type Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Molecular Diagnostics Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Prevalence of Infectious Diseases & Cancer
      • 3.2.1.2. Increasing Research Activities Set to Bring Down Cost of Testing and Boost Market Growth
      • 3.2.1.3. Increasing Awareness in General Public is a Great Opportunity for Market Expansion
    • 3.2.2. Restraints
      • 3.2.2.1. Unfavorable Reimbursement Due to Lack of Proper Billing Guidelines in Different Regions
      • 3.2.2.2. Others
    • 3.2.3. Opportunity
      • 3.2.3.1. Growth Opportunities in Emerging Economies
      • 3.2.3.2. Rising demand for genetic tests is a big opportunity for global molecular diagnostics market
      • 3.2.3.3. Others
    • 3.2.4. Challenges
      • 3.2.4.1. Strict Regulatory Framework
      • 3.2.4.2. Introduction of Alternative Technologies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Bargaining Power of Buyers
    • 3.3.3. Threat of New Entrants
    • 3.3.4. Threat of Substitutes
    • 3.3.5. Intensity of Rivalry

4. Global Molecular Diagnostics Market Overview

  • 4.1. Market Size & Forecast by Value, 2018-2028
    • 4.1.1. By Value (USD Billion)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Instruments
      • 4.2.1.2. Reagents
      • 4.2.1.3. Others
    • 4.2.2. By Technology
      • 4.2.2.1. Polymerase Chain Reaction (PCR)
      • 4.2.2.2. Hybridization
      • 4.2.2.3. DNA Sequencing
      • 4.2.2.4. Microarray
      • 4.2.2.5. Isothermic Nucleic Acid Amplification Technology (INAAT)
      • 4.2.2.6. Others
    • 4.2.3. By End User
      • 4.2.3.1. Diagnostic Laboratories
      • 4.2.3.2. Hospitals & Clinics
      • 4.2.3.3. Research Institutions
      • 4.2.3.4. Others
    • 4.2.4. By Application
      • 4.2.4.1. Infectious Disease
      • 4.2.4.2. Oncology
      • 4.2.4.3. Pharmacogenomics
      • 4.2.4.4. Genetic Testing
      • 4.2.4.5. Blood Screening
      • 4.2.4.6. Neurological Disease
      • 4.2.4.7. Cardiovascular Disease
      • 4.2.4.8. Microbiology
      • 4.2.4.9. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia Pacific
      • 4.2.5.4. Latin America
      • 4.2.5.5. Middle East and Africa

5. North America Molecular Diagnostics Market

    • 5.1.1. Market Size & Forecast by Value, 2018-2028
    • 5.1.2. By Value (USD Billion)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By Technology
    • 5.2.3. By End User
    • 5.2.4. By Application
    • 5.2.5. By Country
      • 5.2.5.1. United States
      • 5.2.5.1.1. By Product
      • 5.2.5.1.2. By Technology
      • 5.2.5.1.3. By End User
      • 5.2.5.1.4. By Application
      • 5.2.5.2. Canada
      • 5.2.5.2.1. By Product
      • 5.2.5.2.2. By Technology
      • 5.2.5.2.3. By End User
      • 5.2.5.2.4. By Application

6. Europe Molecular Diagnostics Market

  • 6.1. Market Size & Forecast by Value, 2018-2028
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technology
    • 6.2.3. By End User
    • 6.2.4. By Application
    • 6.2.5. By Country
      • 6.2.5.1. Germany
      • 6.2.5.1.1. By Product
      • 6.2.5.1.2. By Technology
      • 6.2.5.1.3. By End User
      • 6.2.5.1.4. By Application
      • 6.2.5.2. United Kingdom
      • 6.2.5.2.1. By Product
      • 6.2.5.2.2. By Technology
      • 6.2.5.2.3. By End User
      • 6.2.5.2.4. By Application
      • 6.2.5.3. Italy
      • 6.2.5.3.1. By Product
      • 6.2.5.3.2. By Technology
      • 6.2.5.3.3. By End User
      • 6.2.5.3.4. By Application
      • 6.2.5.4. France
      • 6.2.5.4.1. By Product
      • 6.2.5.4.2. By Technology
      • 6.2.5.4.3. By End User
      • 6.2.5.4.4. By Application
      • 6.2.5.5. Spain
      • 6.2.5.5.1. By Product
      • 6.2.5.5.2. By Technology
      • 6.2.5.5.3. By End User
      • 6.2.5.5.4. By Application
      • 6.2.5.6. The Netherlands
      • 6.2.5.6.1. By Product
      • 6.2.5.6.2. By Technology
      • 6.2.5.6.3. By End User
      • 6.2.5.6.4. By Application
      • 6.2.5.7. Belgium
      • 6.2.5.7.1. By Product
      • 6.2.5.7.2. By Technology
      • 6.2.5.7.3. By End User
      • 6.2.5.7.4. By Application
      • 6.2.5.8. NORDIC Countries
      • 6.2.5.8.1. By Product
      • 6.2.5.8.2. By Technology
      • 6.2.5.8.3. By End User
      • 6.2.5.8.4. By Application
      • 6.2.5.9. Rest of Europe
      • 6.2.5.9.1. By Product
      • 6.2.5.9.2. By Technology
      • 6.2.5.9.3. By End User
      • 6.2.5.9.4. By Application

7. Asia Pacific Molecular Diagnostics Market

  • 7.1. Market Size & Forecast by Value, 2018-2028
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By End User
    • 7.2.4. By Application
    • 7.2.5. By Country
      • 7.2.5.1. China
      • 7.2.5.1.1. By Product
      • 7.2.5.1.2. By Technology
      • 7.2.5.1.3. By End User
      • 7.2.5.1.4. By Application
      • 7.2.5.2. India
      • 7.2.5.2.1. By Product
      • 7.2.5.2.2. By Technology
      • 7.2.5.2.3. By End User
      • 7.2.5.2.4. By Application
      • 7.2.5.3. Japan
      • 7.2.5.3.1. By Product
      • 7.2.5.3.2. By Technology
      • 7.2.5.3.3. By End User
      • 7.2.5.3.4. By Application
      • 7.2.5.4. South Korea
      • 7.2.5.4.1. By Product
      • 7.2.5.4.2. By Technology
      • 7.2.5.4.3. By End User
      • 7.2.5.4.4. By Application
      • 7.2.5.5. Australia & New Zealand
      • 7.2.5.5.1. By Product
      • 7.2.5.5.2. By Technology
      • 7.2.5.5.3. By End User
      • 7.2.5.5.4. By Application
      • 7.2.5.6. Indonesia
      • 7.2.5.6.1. By Product
      • 7.2.5.6.2. By Technology
      • 7.2.5.6.3. By End User
      • 7.2.5.6.4. By Application
      • 7.2.5.7. Malaysia
      • 7.2.5.7.1. By Product
      • 7.2.5.7.2. By Technology
      • 7.2.5.7.3. By End User
      • 7.2.5.7.4. By Application
      • 7.2.5.8. Singapore
      • 7.2.5.8.1. By Product
      • 7.2.5.8.2. By Technology
      • 7.2.5.8.3. By End User
      • 7.2.5.8.4. By Application
      • 7.2.5.9. Philippines
      • 7.2.5.9.1. By Product
      • 7.2.5.9.2. By Technology
      • 7.2.5.9.3. By End User
      • 7.2.5.9.4. By Application
      • 7.2.5.10. Vietnam
      • 7.2.5.10.1. By Product
      • 7.2.5.10.2. By Technology
      • 7.2.5.10.3. By End User
      • 7.2.5.10.4. By Application
      • 7.2.5.11. Rest of Asia Pacific
      • 7.2.5.11.1. By Product
      • 7.2.5.11.2. By Technology
      • 7.2.5.11.3. By End User
      • 7.2.5.11.4. By Application

8. Latin America Molecular Diagnostics Market

  • 8.1. Market Size & Forecast by Value, 2018-2028
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By End User
    • 8.2.4. By Application
    • 8.2.5. By Country
      • 8.2.5.1. Brazil
      • 8.2.5.1.1. By Product
      • 8.2.5.1.2. By Technology
      • 8.2.5.1.3. By End User
      • 8.2.5.1.4. By Application
      • 8.2.5.2. Mexico
      • 8.2.5.2.1. By Product
      • 8.2.5.2.2. By Technology
      • 8.2.5.2.3. By End User
      • 8.2.5.2.4. By Application
      • 8.2.5.3. Argentina
      • 8.2.5.3.1. By Product
      • 8.2.5.3.2. By Technology
      • 8.2.5.3.3. By End User
      • 8.2.5.3.4. By Application
      • 8.2.5.4. Peru
      • 8.2.5.4.1. By Product
      • 8.2.5.4.2. By Technology
      • 8.2.5.4.3. By End User
      • 8.2.5.4.4. By Application
      • 8.2.5.5. Colombia
      • 8.2.5.5.1. By Product
      • 8.2.5.5.2. By Technology
      • 8.2.5.5.3. By End User
      • 8.2.5.5.4. By Application
      • 8.2.5.6. Rest of Latin America
      • 8.2.5.6.1. By Product
      • 8.2.5.6.2. By Technology
      • 8.2.5.6.3. By End User
      • 8.2.5.6.4. By Application

9. Middle East & Africa Molecular Diagnostics Market

  • 9.1. Market Size & Forecast by Value, 2018-2028
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By End User
    • 9.2.4. By Application
    • 9.2.5. By Country
      • 9.2.5.1. Saudi Arabia
      • 9.2.5.1.1. By Product
      • 9.2.5.1.2. By Technology
      • 9.2.5.1.3. By End User
      • 9.2.5.1.4. By Application
      • 9.2.5.2. UAE
      • 9.2.5.2.1. By Product
      • 9.2.5.2.2. By Technology
      • 9.2.5.2.3. By End User
      • 9.2.5.2.4. By Application
      • 9.2.5.3. Qatar
      • 9.2.5.3.1. By Product
      • 9.2.5.3.2. By Technology
      • 9.2.5.3.3. By End User
      • 9.2.5.3.4. By Application
      • 9.2.5.4. Kuwait
      • 9.2.5.4.1. By Product
      • 9.2.5.4.2. By Technology
      • 9.2.5.4.3. By End User
      • 9.2.5.4.4. By Application
      • 9.2.5.5. Iran
      • 9.2.5.5.1. By Product
      • 9.2.5.5.2. By Technology
      • 9.2.5.5.3. By End User
      • 9.2.5.5.4. By Application
      • 9.2.5.6. South Africa
      • 9.2.5.6.1. By Product
      • 9.2.5.6.2. By Technology
      • 9.2.5.6.3. By End User
      • 9.2.5.6.4. By Application
      • 9.2.5.7. Nigeria
      • 9.2.5.7.1. By Product
      • 9.2.5.7.2. By Technology
      • 9.2.5.7.3. By End User
      • 9.2.5.7.4. By Application
      • 9.2.5.8. Kenya
      • 9.2.5.8.1. By Product
      • 9.2.5.8.2. By Technology
      • 9.2.5.8.3. By End User
      • 9.2.5.8.4. By Application
      • 9.2.5.9. Egypt
      • 9.2.5.9.1. By Product
      • 9.2.5.9.2. By Technology
      • 9.2.5.9.3. By End User
      • 9.2.5.9.4. By Application
      • 9.2.5.10. Morocco
      • 9.2.5.10.1. By Product
      • 9.2.5.10.2. By Technology
      • 9.2.5.10.3. By End User
      • 9.2.5.10.4. By Application
      • 9.2.5.11. Algeria
      • 9.2.5.11.1. By Product
      • 9.2.5.11.2. By Technology
      • 9.2.5.11.3. By End User
      • 9.2.5.11.4. By Application
      • 9.2.5.12. Rest of Middle East & Africa
      • 9.2.5.12.1. By Product
      • 9.2.5.12.2. By Technology
      • 9.2.5.12.3. By End User
      • 9.2.5.12.4. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Company Market Share Analysis, 2021
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, and others)

11. Impact of Covid-19 on Global Molecular Diagnostics Market Industry

12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)

  • 12.1. ABOTT LABORATORIES
  • 12.2. Agilent Technologies Inc.
  • 12.3. BECTON DICKINSON AND COMPANY
  • 12.4. BIOMERIEUX SA
  • 12.5. HOFFMON LA-ROCHE LTD
  • 12.6. GRIFOLS S.A.
  • 12.7. HOLOGIC INC.
  • 12.8. QIAGEN INC
  • 12.9. SIEMENS AG
  • 12.10. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations